Correlation Between CureVac NV and Amylyx Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on CureVac NV and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Amylyx Pharmaceuticals.

Diversification Opportunities for CureVac NV and Amylyx Pharmaceuticals

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between CureVac and Amylyx is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of CureVac NV i.e., CureVac NV and Amylyx Pharmaceuticals go up and down completely randomly.

Pair Corralation between CureVac NV and Amylyx Pharmaceuticals

Given the investment horizon of 90 days CureVac NV is expected to generate 35.63 times less return on investment than Amylyx Pharmaceuticals. But when comparing it to its historical volatility, CureVac NV is 1.78 times less risky than Amylyx Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  507.00  in Amylyx Pharmaceuticals on August 30, 2024 and sell it today you would earn a total of  67.00  from holding Amylyx Pharmaceuticals or generate 13.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

CureVac NV  vs.  Amylyx Pharmaceuticals

 Performance 
       Timeline  
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CureVac NV is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
Amylyx Pharmaceuticals 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Amylyx Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Amylyx Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

CureVac NV and Amylyx Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CureVac NV and Amylyx Pharmaceuticals

The main advantage of trading using opposite CureVac NV and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.
The idea behind CureVac NV and Amylyx Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world